Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BGLC BioNexus Gene Lab	$5.59 -0.9%	$5.17	$2.01 ▼ $15.60	$10.13M	5.34	3.07 million shs	45,199 shs
MGRX Mangoceuticals	$1.87 +12.5%	$1.68	$1.32 ▼ $7.66	$17.51M	2.42	90,546 shs	310,909 shs
SSY SunLink Health Systems	$1.12 +16.6%	$1.05	$0.62 ▼ $1.91	$7.88M	1.16	145,367 shs	243,934 shs
VSEE VSee Health	$0.84 +1.0%	$1.15	$0.62 ▼ $3.54	N/A	N/A	N/A	11,722 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BGLC BioNexus Gene Lab	+0.18%	+6.02%	+15.10%	+54.95%	+33.49%
MGRX Mangoceuticals	-3.93%	+6.20%	-3.93%	-12.06%	-97.31%
SSY SunLink Health Systems	0.00%	0.00%	-17.72%	+31.34%	+38.15%
VSEE VSee Health	+1.22%	+2.47%	-37.59%	-35.16%	-51.46%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BGLC BioNexus Gene Lab	0.027 of 5 stars	0.0	2.0	0.0	0.0	0.4	0.0	0.0
MGRX Mangoceuticals	0.5741 of 5 stars	0.0	2.0	0.0	0.0	1.9	1.7	0.6
SSY SunLink Health Systems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VSEE VSee Health	1.514 of 5 stars	2.0	4.0	0.0	0.0	1.7	0.0	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BGLC BioNexus Gene Lab	0.00	N/A	N/A	N/A
MGRX Mangoceuticals	0.00	N/A	N/A	N/A
SSY SunLink Health Systems	0.00	N/A	N/A	N/A
VSEE VSee Health	4.00	Strong Buy	$5.00	496.59% Upside

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BGLC BioNexus Gene Lab	$9.51M	1.06	N/A	N/A	$4.19 per share	1.33
MGRX Mangoceuticals	$516.03K	38.18	N/A	N/A	$1.83 per share	1.02
SSY SunLink Health Systems	$31.09M	0.25	N/A	N/A	$2.27 per share	0.49
VSEE VSee Health	N/A	N/A	N/A	N/A	($3.40) per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BGLC BioNexus Gene Lab	-$1.60M	N/A	0.00	∞	N/A	-30.70%	-35.54%	-29.08%	N/A
MGRX Mangoceuticals	-$8.71M	-$3.86	N/A	∞	N/A	-2,757.86%	-85.01%	-78.08%	N/A
SSY SunLink Health Systems	-$1.53M	$0.24	4.66	∞	N/A	5.55%	-18.98%	-14.79%	N/A
VSEE VSee Health	-$4.41M	N/A	0.00	∞	N/A	N/A	N/A	N/A	9/22/2025 (Estimated)

Latest VSEE, BGLC, SSY, and MGRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/18/2025	Q2 2025	BGLC BioNexus Gene Lab	N/A	-$0.34	N/A	-$0.34	N/A	$2.26 million
8/14/2025	Q2 2025	MGRX Mangoceuticals	N/A	-$0.57	N/A	-$0.57	N/A	$0.17 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BGLC BioNexus Gene Lab	N/A	N/A	N/A	N/A	N/A
MGRX Mangoceuticals	N/A	N/A	N/A	N/A	N/A
SSY SunLink Health Systems	N/A	N/A	N/A	N/A	N/A
VSEE VSee Health	N/A	N/A	N/A	N/A	N/A

Latest VSEE, BGLC, SSY, and MGRX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2025	SSY SunLink Health Systems	special	$0.10			7/29/2025	7/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BGLC BioNexus Gene Lab	N/A	3.63	2.94
MGRX Mangoceuticals	N/A	0.07	0.07
SSY SunLink Health Systems	N/A	3.91	3.50
VSEE VSee Health	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BGLC BioNexus Gene Lab	18.85%
MGRX Mangoceuticals	56.72%
SSY SunLink Health Systems	23.67%
VSEE VSee Health	1.01%

Insider Ownership

Company	Insider Ownership
BGLC BioNexus Gene Lab	0.70%
MGRX Mangoceuticals	16.00%
SSY SunLink Health Systems	27.90%
VSEE VSee Health	6.59%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BGLC BioNexus Gene Lab	30	1.80 million	1.78 million	Not Optionable
MGRX Mangoceuticals	3	10.54 million	8.85 million	Not Optionable
SSY SunLink Health Systems	1,376	7.04 million	5.08 million	Not Optionable
VSEE VSee Health	N/A	3.60 million	3.37 million	N/A

VSEE, BGLC, SSY, and MGRX Headlines

Recent News About These Companies

VSee Health receives expected additional notice of deficiency from Nasdaq related to delayed filing of Form 10-Q

August 22, 2025 | biznes.newseria.plB

VSee Health Faces Nasdaq Delisting Notice

August 22, 2025 | tipranks.com

VSee Health, Inc. (NASDAQ:VSEE) Sees Significant Decrease in Short Interest

August 18, 2025 | americanbankingnews.com

VSee Health Appeals NASDAQ Staff Delisting Notice

August 12, 2025 | accessnewswire.comA

VSee Health stock plummets as Nasdaq delisting looms

August 11, 2025 | au.investing.com

CORRECTING and REPLACING VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

July 16, 2025 | businesswire.com

VSee Health stock soars after launching AI doctor notes solution

July 14, 2025 | in.investing.com

VSee Health Stock Jumps After Unveiling AI-Powered Doctor Notes Tool

July 14, 2025 | msn.com

VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

July 14, 2025 | businesswire.com

VSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare Market

June 26, 2025 | theglobeandmail.com

VSee Health selected for NIH-funded stroke recovery telerehab trial

June 25, 2025 | investing.com

VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial - Business Wire

June 24, 2025 | businesswire.com

VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

June 23, 2025 | businesswire.com

VSee Health faces Nasdaq compliance issue over late filings

June 1, 2025 | investing.com

VSee Health faces Nasdaq delisting over late filing

June 1, 2025 | uk.investing.com

VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

May 30, 2025 | businesswire.com

VSee Health launches telehealth initiative in the Philippines

May 17, 2025 | investing.com

VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines

May 16, 2025 | businesswire.com

VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

May 12, 2025 | businesswire.com

VSee Health Inc. Faces Nasdaq Delisting Over Late Filing

May 10, 2025 | investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

VSEE, BGLC, SSY, and MGRX Company Descriptions

BioNexus Gene Lab NASDAQ:BGLC

$5.59 -0.05 (-0.89%)

Closing price 04:00 PM Eastern

Extended Trading

$5.39 -0.20 (-3.60%)

As of 08:00 PM Eastern

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Mangoceuticals NASDAQ:MGRX

$1.87 +0.21 (+12.52%)

Closing price 04:00 PM Eastern

Extended Trading

$1.86 -0.02 (-0.80%)

As of 07:47 PM Eastern

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

SunLink Health Systems NYSE:SSY

$1.12 +0.16 (+16.56%)

Closing price 08/14/2025

Extended Trading

$1.12 0.00 (0.00%)

As of 08/14/2025 08:00 PM Eastern

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

VSee Health NASDAQ:VSEE

$0.84 +0.01 (+0.98%)

Closing price 03:52 PM Eastern

Extended Trading

$0.84 +0.00 (+0.23%)

As of 04:37 PM Eastern

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time